# Occult Thyroid Carcinoma Localized to Three Cervical Lymph Nodes Without Primary Origin in the Thyroid Gland: A Case Report

**Authors:** Daisuke Murayama, Yasunori Nishida, Shun Hishikawa, Ryosuke Hirano, Toko Hashizume, Koji Azuhata, Hisashi Shimojo, Nobuo Ito, Osamu Mishima

PMC · DOI: 10.1155/crie/3603326 · Case Reports in Endocrinology · 2026-02-23

## TL;DR

A case report describes a patient with thyroid cancer metastases in lymph nodes but no primary tumor in the thyroid gland.

## Contribution

This case highlights the rare occurrence of occult thyroid carcinoma without a primary tumor and its management.

## Key findings

- No primary thyroid carcinoma was found despite metastases in cervical lymph nodes.
- Thyroglobulin levels were elevated and remained low post-surgery with no recurrence.
- The patient was diagnosed with pT0N1bM0 Stage II occult thyroid carcinoma.

## Abstract

Occult thyroid carcinoma (OTC) involves cervical lymph node metastases without primary papillary thyroid carcinoma (PTC). A 57‐year‐old man presented with a left neck mass. Ultrasonography (US) revealed a mass in the left cervical node (inferior internal jugular node, Level IV). Positron emission tomography/computed tomography (PET/CT) and fine needle aspiration biopsy indicated suspected PTC metastasis. The serum thyroglobulin (Tg) level was elevated. Total thyroidectomy and bilateral central neck and left cervical dissection revealed no thyroid carcinoma, while the left cervical node showed ground glass nuclei and proliferation. Our diagnosis was PTC with no primary origin, pT0N1bM0 Stage II. Due to a low risk of recurrence, we initiated thyroid‐stimulating hormone (TSH) suppression therapy. Tg levels remained low 4 years postoperatively with no signs of recurrence. The optimal management of OTC cases remains unclear and blood tests (Tg levels), risk of recurrence, and patient characteristics must be considered.

## Linked entities

- **Diseases:** thyroid carcinoma (MONDO:0015075), papillary thyroid carcinoma (MONDO:0005075)

## Full-text entities

- **Genes:** TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, OTC (ornithine transcarbamylase) [NCBI Gene 5009] {aka OCTD, OTC1, OTCD, OTCase}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}
- **Diseases:** cervical lymph node metastasis (MESH:D008207), hepatocellular carcinoma (MESH:D006528), ectopic thyroid tissue (MESH:D002828), adenomatous goiter (MESH:D006042), renal cell carcinoma (MESH:D002292), ectopic thyroid gland (MESH:C566852), papillary carcinoma (MESH:D002291), metastases (MESH:D009362), hypertension (MESH:D006973), Occult Thyroid Carcinoma (MESH:D013964), PTC (MESH:D000077273), Hashimoto's thyroiditis (MESH:D050031), cervical swelling (MESH:D002575), fibrosis (MESH:D005355), melanoma (MESH:D008545), cancer (MESH:D009369), benign lateral neck (MESH:D006258), anaplastic (MESH:D002277)
- **Chemicals:** RAI (-), TSH (MESH:D013972), Tc-99m (MESH:D013667)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** V600E

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927892/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927892/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927892/full.md

---
Source: https://tomesphere.com/paper/PMC12927892